Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

Research output: Contribution to journalArticle

Research Projects

  1. Acute Myeloid Leukaemia Trials; Long-term follow-up, analysis and reporting

    Keith Wheatley &

    MEDICAL RESEARCH COUNCIL

    1/10/0330/09/09

    Project: Research Councils